Current Cancer Drug Targets

Journal Title：Current Cancer Drug Targets

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

《当前癌症药物靶点》旨在涵盖与癌症有关的当代分子药物靶点的药物化学、药理学、分子生物学、基因组学和生物化学方面的所有最新和杰出进展，例如疾病特异性蛋白质、受体、酶和基因。

《当前癌症药物靶点》发表原创研究文章、信件、评论/小评论、药物临床试验研究和客座编辑专题，由该领域的领导者撰写，涵盖与癌症有关的一系列药物靶点的当前主题。

随着抗癌药物发现的新型人类药物靶点的发现、鉴定、表征和验证不断增长；这本期刊已成为所有参与药物发现和开发的制药科学家的必读读物。

Current Cancer Drug Targets创刊于2001年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约1月 ，影响因子指数2.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。